Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001209191-22-051012

Options or other derivatives

  • Director acquired 10,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Islam Khalid Director 2022-09-20 Grant or award · Stock Option (right to buy) +10,500 10,500 D
Loading xslF345X03/doc4.xml…